Biofrontera
BFRI
12 hedge funds and large institutions have $2.66M invested in Biofrontera in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0.03% more ownership
Funds ownership: 0.23% → 0.27% (+0.03%)
14% less funds holding
Funds holding: 14 → 12 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
50% less capital invested
Capital invested by funds: $5.29M → $2.66M (-$2.63M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$328K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$324K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$183K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$144K |
| 5 |
Two Sigma Advisers
New York
|
+$63.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Verition Fund Management
Greenwich,
Connecticut
|
-$420K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$384K |
| 3 |
BA
Bard Associates
Chicago,
Illinois
|
-$351K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$103K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.68K |
BFRI Hedge Fund Activity: Q1 2022 in Review
12 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q1 2022, worth a combined $2.66M — down 50% from $5.29M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BFRI and 5 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was BlackRock, adding an estimated $328K. The largest seller was Verition Fund Management, exiting entirely with an estimated $420K sold.
- 12 institutional investors held Biofrontera (BFRI) as of Q1 2022, down from 14 in Q4 2021.
- Funds reported $2.66M of Biofrontera stock for Q1 2022, down 50% quarter-over-quarter.
- 5 funds opened new Biofrontera positions in Q1 2022 and 7 closed out, a net change of -2 holders.
- The largest Biofrontera buyer in Q1 2022 was BlackRock, an estimated $328K added.
- The largest Biofrontera seller in Q1 2022 was Verition Fund Management, an estimated $420K sold.
Based on aggregated 13F filings for Q1 2022.